ClinicalTrials.gg

Terns, Inc. clinical trials

Acquired by Merck & Co., Inc, May 5, 2026 · source ↗

The registry lists 7 studies whose lead sponsor is Terns, Inc. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Before and after it joined Merck & Co., Inc

First submitted before Terns, Inc. became part of Merck & Co., Inc
5
First submitted after Terns, Inc. became part of Merck & Co., Inc
2
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Terns, Inc.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 7 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now114%
  • Completed686%

Phase

  • Phase 24
  • Phase 14

Where

  • United States7
  • Germany1
  • Spain1
  • United Kingdom1
  • Australia1
  • France1

Over the years

  1. 120
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4 studies
  • Terns, Inc.3 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 7 of 7. All Merck & Co., Inc studies →